海洋生物技术市场规模、份额和成长分析（按类型、技术、应用、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球海洋生物技术市场规模将达到 69.5 亿美元，到 2025 年将成长至 74.3 亿美元，到 2033 年将成长至 126.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.9%。

全球海洋生物技术市场正经历显着成长，它利用海洋丰富的资源来推动医疗保健、农业和能源领域的创新产品。该领域利用海洋生物的特异性特性，开发包括治疗药物和生质燃料在内的生物技术产品。市场潜力巨大，这得益于对永续和环保解决方案的日益增长的需求，以及慢性病患病率的上升。然而，高昂的研发成本、有限的海洋资源取得以及监管障碍等挑战依然存在。但生物技术的进步和行业相关人员之间日益密切的合作预计将推动市场成长。值得关注的趋势包括海洋酵素和海洋生医材料在各行业的应用不断扩展，凸显了该领域巨大的创新和发展机会。

推动全球海洋生物技术市场发展的因素

人们对环境议题的日益关注以及对永续性的追求，显着提升了各行各业对环保产品的需求。在此背景下，海洋生物技术正成为永续解决方案的重要来源，为工业应用提供创新替代方案，例如海洋来源的酵素、生质燃料和生质塑胶。例如，一些公司正在利用藻类生产可生物降解的生质塑胶材料，作为传统塑胶的永续替代品。这一趋势反映了一种更广泛的趋势，即以符合生态责任的方式利用海洋资源，并致力于建立更永续的未来。

抑制全球海洋生物技术市场

全球海洋生物技术市场面临诸多限制因素，主要源自于海洋衍生产品研发的高成本。这个复杂过程包括识别和培养多种海洋生物，以及提取和纯化其中有价值的生物活性化合物。光是培养和萃取一种海洋衍生化合物的成本就十分巨大，往往高达数百万美元。这些高昂的成本对海洋生物技术产品的成长和商业化都构成了挑战，阻碍了该产业充分利用海洋环境中丰富的资源。

全球海洋生物技术市场趋势

海洋生医材料的应用是全球海洋生物技术市场的一大趋势，尤其是在医疗保健、组织工程和再生医学等领域。海洋胶原蛋白等资源具有优于传统哺乳动物来源材料的功效和生物相容性，研究人员正利用这些资源探索其在创伤治疗和组织再生方面的创新应用。鑑于海洋生物活性化合物在医疗保健解决方案中具有永续和环境友善替代方案的巨大潜力，相关投资和研究正在蓬勃发展。随着技术的进步，海洋生医材料材料的整合应用有望进一步推进，从而改善治疗效果并促进跨学科合作。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球海洋生物技术市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 生物活性物质
• 生物材料

全球海洋生物技术市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 微生物的分离与培养
• 与文化无关的技术

全球海洋生物技术市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 水产养殖和食品
• 环境/人体健康
• 药物发现

全球海洋生物技术市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 食品工业
• 製药和生物技术产业
• 化工
• 化妆品产业

全球海洋生物技术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• BASF（Germany）
• Key Developments
• Cyanotech Corp.（USA）
• Kerry Group（Ireland）
• Corbion（Netherlands）
• FMC Corp.（USA）
• Marine Biotech（USA）
• Royal DSM（Netherlands）
• TransGen Biotech Co., Ltd.（China）
• Olmix Group（France）
• Ittinsect（Italy）
• BRAIN Biotech AG（Germany）
• Biotech Marine（France）
• Marinova Pty Ltd（Australia）
• Pharma Mar, SA（Spain）
• GlycoMar Ltd.（UK）
• Aker BioMarine ASA（Norway）
• oceanBASIS GmbH（Germany）
• Primex Iceland（Iceland）
• New England Biolabs（NEB）（USA）

结论与建议

Global Marine Biotechnology Market size was valued at USD 6.95 Billion in 2024 and is poised to grow from USD 7.43 Billion in 2025 to USD 12.67 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global marine biotechnology market is experiencing significant growth, leveraging the abundant resources of the oceans to innovate products across medicine, agriculture, and energy. This sector capitalizes on the unique properties of marine organisms to produce biotechnological advancements, including therapeutics and biofuels. A surge in demand for sustainable and eco-friendly solutions, alongside the rise in chronic disease prevalence, underscores the market potential. Challenges such as high R&D costs, restricted access to marine resources, and regulatory barriers persist. However, advancements in biotechnology and an increase in collaborations among industry stakeholders are poised to propel market growth. Notable trends include the rising application of marine-derived enzymes and marine biomaterials in diverse industries, highlighting vast opportunities for innovation and development in this space.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Marine Biotechnology Market Segments Analysis

Global Marine Biotechnology Market is segmented by Type, Technology, Application, End-user and region. Based on Type, the market is segmented into Bio Active Substance and Bio Materials. Based on Technology, the market is segmented into Isolation and Cultivation of Microorganisms and Culture-Independent Techniques. Based on Application, the market is segmented into Aquaculture and Food Products, Environment & Human Health and Drug Discovery. Based on End-user, the market is segmented into Food Industry, Pharmaceutical and Biotechnology Industry, Chemical Industry and Cosmetic Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Marine Biotechnology Market

The heightened awareness surrounding environmental issues and the push for sustainability have significantly boosted the demand for eco-friendly products across numerous sectors. In this context, marine biotechnology emerges as a vital source of sustainable solutions, providing innovative alternatives like marine-derived enzymes for industrial uses, as well as biofuels and bioplastics. For example, some companies are harnessing algae to create biodegradable bioplastic materials, which serve as sustainable substitutes for conventional plastics. This trend reflects a broader movement toward utilizing marine resources in a way that aligns with ecological responsibility and contributes to a more sustainable future.

Restraints in the Global Marine Biotechnology Market

The Global Marine Biotechnology market faces significant constraints primarily due to the high costs associated with the research and development of marine-derived products. This intricate process encompasses the identification and cultivation of diverse marine organisms, alongside the extraction and purification of valuable bioactive compounds. The financial burden of cultivating and extracting even a single marine-derived compound can reach substantial amounts, often totaling several hundred thousand dollars. Such steep expenses pose challenges to both the growth and commercialization of marine biotechnology products, hindering the industry's potential to fully capitalize on the wealth of resources available in marine environments.

Market Trends of the Global Marine Biotechnology Market

The Global Marine Biotechnology market is witnessing a significant trend towards the utilization of marine-derived biomaterials, particularly in areas such as medicine, tissue engineering, and regenerative therapies. Leveraging the unique properties of resources like marine collagen, which surpasses traditional mammalian alternatives in efficacy and biocompatibility, researchers are exploring innovative applications in wound healing and tissue regeneration. This focus on bioactive compounds derived from marine sources is driving investment and research, as industries recognize the potential for sustainable, environmentally friendly alternatives in healthcare solutions. As technologies advance, the integration of marine biomaterials is expected to evolve, enhancing therapeutic outcomes and fostering interdisciplinary collaboration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Marine Biotechnology Market Size by Type & CAGR (2026-2033)

• Market Overview
• Bio Active Substance
• Bio Materials

Global Marine Biotechnology Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Global Marine Biotechnology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery

Global Marine Biotechnology Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Food Industry
• Pharmaceutical and Biotechnology Industry
• Chemical Industry
• Cosmetic Industry

Global Marine Biotechnology Market Size & CAGR (2026-2033)

• North America (Type, Technology, Application, End-user)
  • US
  • Canada
• Europe (Type, Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Cyanotech Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Biotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ittinsect (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRAIN Biotech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Marine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Mar, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aker BioMarine ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• oceanBASIS GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primex Iceland (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (NEB) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations